A clinical trial examining the efficacy of two devices to monitor and detect atrial fibrillation (AF), or an irregular heartbeat, in ischemic stroke patients -- one an implantable device that monitors over 12 months, the other an external device that monitors over a 30-day period -- found the implantable device is more than three times more effective in detecting AF.
from Latest Science News -- ScienceDaily https://ift.tt/34D0bcj
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment